UK markets close in 4 hours 7 minutes

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3300-0.0500 (-3.62%)
At close: 04:00PM EDT
1.3700 +0.04 (+3.01%)
After hours: 07:58PM EDT
Sign in to post a message.
  • D
    Don
    Easy buy right here under 2. Do the basic math of shares, cash, and debt. Then look at drugs in the pipeline. 4 dollars minimum.
  • D
    Dragan
    They have cash and pipelines to last another 1-2 years:
    "In connection with this development, Spero announced that it is undertaking a reduction in its workforce by approximately 75% and a restructuring of its operations to reduce operating costs and reallocate resources towards the clinical development programs of SPR720 and SPR206, while continuing engagement with the FDA on the appropriate path forward for tebipenem HBr. Based on the anticipated cost-savings of this restructuring and other assumptions, Spero anticipates it will be able to fund its planned operating expenses and capital expenditure requirements pursuant to the priorities of its strategic refocusing through late 2023".....
  • T
    Trevor
    Red to green soon ….. still holding this one ….. midday spike coming ….. $3 written all over it …..
  • T
    Terminal Gravity
    SPRO "Please buy our company."
    Buyer "How much?"
    SPRO "No cost to you. We'll actually pay you over $100 million in cash for the transaction."
    Buyer "Is this a scam?"
    SPRO "No, it's just the irrational nature of the stock market. To note, this offer may not be around for long."
  • T
    Terminal Gravity
    Calling large pharma companies. You can buy a company trading at less than cash and also grab all of their IP.

    Understand investors must be frustrated but this is quite insane. You could put an offer in for the entire company at $3 per share or double current price in the premarket, shut the doors and pocket close to $10 million in cash. 😂
  • S
    Stupid Redd
    Ok took gamble and only brought a 1000 at $1.57 in pre market let’s see how much money I’m about to lose
  • D
    Dragan
    "In connection with this development, Spero announced that it is undertaking a reduction in its workforce by approximately 75% and a restructuring of its operations to reduce operating costs and reallocate resources towards the clinical development programs of SPR720 and SPR206, while continuing engagement with the FDA on the appropriate path forward for tebipenem HBr. Based on the anticipated cost-savings of this restructuring and other assumptions, Spero anticipates it will be able to fund its planned operating expenses and capital expenditure requirements pursuant to the priorities of its strategic refocusing through late 2023.".....
  • T
    Terminal Gravity
    They have $146 million cash on hand and current value in the premarket is $46 million?. Wow, this seems way overcooked on the downside...
  • S
    Stupid Redd
    Oh boy should I buy why it’s under $2 is the question
  • O
    Ok
    Today less than a 1 dollar
  • p
    pedro
    Thanks dude have just contacted her.
  • D
    Dr
    I wonder what the future of tebipenem is now? I can't really decipher from the info they provide. That was the reason i bought this stock in the first place. I think a big pharma like PFE will buy them out but don't see a big premium buyout offer making sense at this point.
  • T
    Trevor
    seems the resistance is building at $2.14 range..... still looking at $3 exit.....
  • D
    Dragan
    4 $ in 1 Year.
  • D
    Don
    $3 by Tuesday. Above average volume with steady gains at the end of last week. Cash rich, low float, buyout possibility.
  • F
    FRANK
    Hi group , I’m thinking about jumping in head first on this one soley for FDA approval - anyone have any thoughts on FDA ?????
  • T
    Trevor
    4 dollars AH seems possible for this stock ….. could even reach 5
  • s
    simon
    I listened to presentation after new restructuring. I does not look like SPRO is worth 1/3 of cash. Very bullish BTW
  • T
    Trading8
    50 cents
  • D
    Don
    Company update on business Monday, May 16th. Sale coming? Time to buy more.